Tenaris S.A. (TS) 28.40 $TS Tenaris Subscribes to

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Tenaris S.A. (TS) 28.40 $TS

Tenaris Subscribes to Additional Shares in Usiminas Capital Increase
Marketwired - Thu Jun 09, 5:05PM CDT
LUXEMBOURG--(Marketwired - Jun 9, 2016) - Tenaris S.A. (NYSE: TS) (BAE: TS) (BMV: TS) (MILAN: TEN) announced today, in connection with the previously-announced issuance of 200 million ordinary shares of Usinas Siderúrgicas de Minas Gerais - Usiminas at BRL 5.0 per share, that all entities within the Ternium/Tenaris Group (including TenarisConfab) have exercised their rights to subscribe to their corresponding portion of the shares left unsubscribed in the initial subscription round.
TEN: 54.38 (-1.07), TS: 28.40 (-0.52)

Tenaris Rises 3.40% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Jun 07, 2:29PM CDT
Tenaris (NYSE:TS) traded in a range yesterday that spanned from a low of $28.25 to a high of $28.88. Yesterday, the shares gained 3.4%, which took the trading range above the 3-day high of $27.85 on volume of 2.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
TS: 28.40 (-0.52)

SmarTrend Watching for Potential Pullback in Shares of Tenaris After 3.40% Gain
Comtex SmarTrend(R) - Tue Jun 07, 2:27PM CDT
Tenaris (NYSE:TS) traded in a range yesterday that spanned from a low of $28.25 to a high of $28.88. Yesterday, the shares gained 3.4%, which took the trading range above the 3-day high of $27.85 on volume of 2.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
TS: 28.40 (-0.52)

Zacks Industry Outlook Highlights: Tenaris, BHP Billiton, Rio Tinto and Vale
Zacks Equity Research - Zacks Investment Research - Fri May 27, 8:30AM CDT
Zacks Industry Outlook Highlights: Tenaris, BHP Billiton, Rio Tinto and Vale
VALE: 4.41 (-0.22), BHP: 26.73 (-1.25), RIO: 27.94 (-0.81), TS: 28.40 (-0.52)

Will the Steel Industry Buckle Under These Factors?
Zacks Equity Research - Zacks Investment Research - Thu May 26, 4:33PM CDT
Will the Steel Industry Buckle Under These Factors?
STLD: 25.88 (-0.32), F: 13.10 (-0.16), BHP: 26.73 (-1.25), NUE: 50.50 (-0.05), VALE: 4.41 (-0.22), AKS: 4.96 (-0.09), RIO: 27.94 (-0.81), TS: 28.40 (-0.52), X: 17.27 (-0.17), MT: 5.29 (-0.12)

Tenaris Participates in Usiminas Capital Increase
Marketwire Canada - Mon May 23, 4:06PM CDT
LUXEMBOURG--(Marketwired - May 23, 2016) - Tenaris S.A. (NYSE: TS) (BAE: TS) (BMV: TS) (MILAN: TEN) announced today, by the expiration of the initial subscription round of the proposed issuance of 200 million ordinary shares of Usinas Siderúrgicas de Minas Gerais - Usiminas at an amount of BRL 5.0 per share, that each of the entities within the Ternium/Tenaris Group, or T/T Group, (including TenarisConfab) has exercised its preemptive rights in connection with the share issuance and has also indicated its willingness to subscribe ordinary shares not subscribed by Usiminas' current shareholders up to a maximum number to be specified in due course.
TEN: 54.38 (-1.07), TS: 28.40 (-0.52)

Tenaris Set to Possibly Rebound After Yesterday's Selloff of 2.23%
Comtex SmarTrend(R) - Mon May 23, 2:06PM CDT
Tenaris (NYSE:TS) traded in a range yesterday that spanned from a low of $25.47 to a high of $26.00. Yesterday, the shares fell 2.2%, which took the trading range below the 3-day low of $25.51 on volume of 1.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
TS: 28.40 (-0.52)

Watch for Tenaris to Potentially Rebound After Falling 2.23% Yesterday
Comtex SmarTrend(R) - Mon May 23, 2:04PM CDT
Tenaris (NYSE:TS) traded in a range yesterday that spanned from a low of $25.47 to a high of $26.00. Yesterday, the shares fell 2.2%, which took the trading range below the 3-day low of $25.51 on volume of 1.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
TS: 28.40 (-0.52)

Surging Earnings Estimates Signal Good News for Tenaris (TS)
Zacks Equity Research - Zacks Investment Research - Tue May 10, 7:40AM CDT
Tenaris (TS) could be an interesting play for investors as it is seeing solid activity on the earnings estimate revision.
TS: 28.40 (-0.52)

Shareholders Approve All Resolutions on the Agenda of Tenaris's Annual General Meeting
Marketwired - Wed May 04, 3:54PM CDT
LUXEMBOURG--(Marketwired - May 4, 2016) -  Tenaris S.A. (NYSE: TS) (BAE: TS) (BMV: TS) (MILAN: TEN) announced that its annual general meeting of shareholders approved today all resolutions on the agenda.
TEN: 54.38 (-1.07), TS: 28.40 (-0.52)

Tenaris Files 2015 Form 20-F
Marketwire Canada - Mon May 02, 4:19PM CDT
Tenaris S.A. (NYSE: TS) (BAE: TS) (BMV: TS) (MILAN: TEN) ("Tenaris" announces that it has filed its annual report on Form 20-F for the year ended December 31, 2015 with the U.S. Securities and Exchange Commission (SEC). The annual report can be downloaded from the SEC website at www.sec.gov and from Tenaris's website at www.tenaris.com/investors. Holders of Tenaris's shares and ADSs, and any other interested parties, may request a hard copy of the annual report, free of charge, through our website at http://ir.tenaris.com/investorkit.cfm.
TEN: 54.38 (-1.07), TS: 28.40 (-0.52)

Look for Shares of Tenaris to Potentially Rebound after Yesterday's 3.25% Sell Off
Comtex SmarTrend(R) - Mon May 02, 4:16PM CDT
Tenaris (NYSE:TS) traded in a range yesterday that spanned from a low of $26.19 to a high of $26.83. Yesterday, the shares fell 3.3%, which took the trading range below the 3-day low of $26.67 on volume of 1.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
TS: 28.40 (-0.52)

Tenaris Announces 2016 First Quarter Results
Marketwire Canada - Wed Apr 27, 9:52PM CDT
Tenaris S.A. (NYSE: TS) (BAE: TS) (BMV: TS) (MILAN: TEN) ("Tenaris" today announced its results for the quarter ended March 31, 2016 in comparison with its results for the quarter ended March 31, 2015.
TEN: 54.38 (-1.07), TX: 19.53 (-0.44), TS: 28.40 (-0.52)

Tenaris Shares Up 25.6% Since SmarTrend's Buy Recommendation (TS)
Comtex SmarTrend(R) - Wed Apr 27, 12:58AM CDT
SmarTrend identified an Uptrend for Tenaris (NYSE:TS) on February 5th, 2016 at $21.39. In approximately 3 months, Tenaris has returned 25.62% as of today's recent price of $26.87.
TS: 28.40 (-0.52)

Downgrade Alert for Tenaris (TS)
Comtex SmarTrend(R) - Tue Apr 26, 3:06AM CDT
Tenaris (NYSE:TS) was downgraded from Neutral to Underperform at Credit Suisse today. The stock closed yesterday at $26.45 on volume of 2.7 million shares, above average daily volume of 2.2 million. Tenaris S.A. manufactures seamless steel pipe products on a global basis. The Company also provides pipe handling, stocking, and distribution services to the oil and gas, energy, and mechanical industries. In addition, Tenaris supplies welded steel pipes for gas pipelines in South America.
TS: 28.40 (-0.52)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fluence Energy Hits Legal Snag: Investors Called to Act

Updated Category News Views 79

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 421

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 134

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 72

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 140

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 93

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 149

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 312

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 87

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading

Top 5 Most Recently Viewed Articles

Nippon Express Europe Partners with Formag for Logistics Support

Updated Category News Views 213

Nippon Express Europe and Formag Form New Logistics Partnership Nippon Express Europe GmbH, part of NIPPON EXPRESS HOLDINGS, INC., has recently signed a cooperation agreement with Ukrainian logistics provider, Formag-Kiev. This significant collaboration aims to provide essential logistical support for the reconstruction of Ukraine. Commitment to Ukrainian Reconstruction...

Continue Reading
Escalating Legal Action Over LIBRA Token Sparks Controversy

Updated Category News Views 265

Legal Developments in the LIBRA Token Case A prominent Argentine lawyer has made headlines by calling for global law enforcement to apprehend a cryptocurrency figure involved in the LIBRA token controversy. Details of the Extradition Request Gregorio Dalbon, known for his defense work with former Argentine President Cristina Fernandez in a prominent corruption matter, has...

Continue Reading
Tesla Prevails in Motion to Dismiss Racial Bias Lawsuit

Updated Category News Views 230

Tesla's Legal Victory Against Racial Bias Allegations Under the direction of Elon Musk, Tesla Inc. (NASDAQ: TSLA) has successfully overturned a significant class action lawsuit that was brought forth by more than 6,000 African American workers. These workers alleged racial discrimination at Tesla's Fremont assembly plant. This ruling is a key moment in the ongoing...

Continue Reading
ZenaTech Unveils Specialized AI Hub to Bolster US Defense Tactics

Updated Category News Views 100

ZenaTech Launches Innovative AI Development Center Vancouver, British Columbia – ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) has taken a significant stride toward advancing artificial intelligence technologies by establishing Zena AI, Inc. This new AI Development Center will focus on crafting specialized AI solutions tailored for defense and homeland security...

Continue Reading
Investors Reminded of Action Timeline Against ICON plc - ICLR

Updated Category News Views 172

Understanding the Legal Proceedings Against ICON plc In an important reminder for shareholders, Kahn Swick & Foti, LLC is emphasizing the critical timeline for investors affected by losses from their holdings in ICON plc (NASDAQ: ICLR). The firm, led by former Louisiana Attorney General Charles C. Foti, Jr., is urging investors who incurred losses exceeding $100,000 to...

Continue Reading